miltefosine has been researched along with Mycoses in 9 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Mycoses: Diseases caused by FUNGI.
Excerpt | Relevance | Reference |
---|---|---|
"Miltefosine is an alkylphosphocholine that shows broad-spectrum in vitro antifungal activities and limited in vivo efficacy in mouse models of cryptococcosis." | 3.79 | Synthesis and antifungal activities of miltefosine analogs. ( Agarwal, AK; Chen, YL; Clark, AM; Heitman, J; Jacob, MR; Khan, SI; Li, XC; Pan, X; Ravu, RR, 2013) |
"Fungal infections are a global health problem with high mortality and morbidity rates." | 3.01 | Miltefosine repositioning: A review of potential alternative antifungal therapy. ( Borba-Santos, LP; Ishida, K; Rozental, S; Spadari, CC, 2023) |
" This study determined the in vitro susceptibility of miltefosine, as a single agent and in combination with posaconazole or voriconazole, against these pathogens." | 1.39 | In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens. ( Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Ravu, RR | 1 |
Chen, YL | 1 |
Jacob, MR | 1 |
Pan, X | 1 |
Agarwal, AK | 1 |
Khan, SI | 1 |
Heitman, J | 1 |
Clark, AM | 1 |
Li, XC | 1 |
Wu, S | 1 |
Wang, Y | 2 |
Liu, N | 2 |
Dong, G | 2 |
Sheng, C | 2 |
Tu, J | 1 |
Spadari, CC | 1 |
Borba-Santos, LP | 1 |
Rozental, S | 1 |
Ishida, K | 1 |
Quaesaet, L | 1 |
Stindel, E | 1 |
Lanternier, F | 1 |
Williams, T | 1 |
Jaffuel, S | 1 |
Moalic, E | 1 |
Garcia Hermoso, D | 1 |
Lortholary, O | 1 |
Ansart, S | 1 |
Biswas, C | 1 |
Sorrell, TC | 2 |
Djordjevic, JT | 1 |
Zuo, X | 1 |
Jolliffe, KA | 1 |
Chen, SC | 1 |
Compain, F | 1 |
Botterel, F | 1 |
Sitterlé, E | 1 |
Paugam, A | 1 |
Bougnoux, ME | 1 |
Dannaoui, E | 1 |
Kesson, AM | 1 |
Bellemore, MC | 1 |
O'Mara, TJ | 1 |
Ellis, DH | 1 |
Ferguson, LM | 1 |
Dreisbach, AW | 1 |
Csongrádi, E | 1 |
Juncos, LA | 1 |
Fulop, T | 1 |
3 reviews available for miltefosine and Mycoses
Article | Year |
---|---|
Tackling Fungal Resistance by Biofilm Inhibitors.
Topics: Animals; Antifungal Agents; Biofilms; Drug Discovery; Drug Resistance, Fungal; Fungi; Humans; Models | 2017 |
Emerging New Targets for the Treatment of Resistant Fungal Infections.
Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Molecular Targeted Therapy; Mycoses | 2018 |
Miltefosine repositioning: A review of potential alternative antifungal therapy.
Topics: Animals; Antifungal Agents; Drug Repositioning; Mycoses; Phosphorylcholine | 2023 |
6 other studies available for miltefosine and Mycoses
Article | Year |
---|---|
Synthesis and antifungal activities of miltefosine analogs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cell Line; C | 2013 |
Miltefosine-based regimen as salvage therapy in Lomentospora prolificans bone and joint infection.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Humans; Male; Mycoses; Osteomyelitis; Phosphorylchol | 2018 |
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylch | 2013 |
In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; M | 2015 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Napht | 2009 |
Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban.
Topics: Antifungal Agents; Antithrombins; Arginine; Blood Coagulation; Coronary Artery Bypass; Humans; Male; | 2013 |